Theodosia Teo

849 total citations
25 papers, 692 citations indexed

About

Theodosia Teo is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Theodosia Teo has authored 25 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Theodosia Teo's work include Cancer-related Molecular Pathways (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Cancer Mechanisms and Therapy (7 papers). Theodosia Teo is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Cancer Mechanisms and Therapy (7 papers). Theodosia Teo collaborates with scholars based in Australia, United Kingdom and China. Theodosia Teo's co-authors include Shudong Wang, Mingfeng Yu, Malika Kumarasiri, Robert Milne, Sarah Diab, Frankie Lam, Matthew J. Sykes, Sunita K. C. Basnet, Hugo Albrecht and Yuchao Yang and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and Molecular Pharmacology.

In The Last Decade

Theodosia Teo

24 papers receiving 688 citations

Peers

Countries citing papers authored by Theodosia Teo

Since Specialization

Citations

This map shows the geographic impact of Theodosia Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodosia Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodosia Teo more than expected).

Fields of papers citing papers by Theodosia Teo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodosia Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodosia Teo. The network helps show where Theodosia Teo may publish in the future.

Co-authorship network of co-authors of Theodosia Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Theodosia Teo. A scholar is included among the top collaborators of Theodosia Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodosia Teo. Theodosia Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma 2025 ·Biomedicine & Pharmacotherapy ·Laychiluh Mekonnen, Theodosia Teo, Benjamin Noll, (unknown), (unknown), Sunita K. C. Basnet, (unknown), Robert Milne, Briony L. Gliddon, Melinda N. Tea, Stuart M. Pitson, Yan Zhou, Lijun Wei, Hui Wang, Jun Liu, Xiang Zhou, Ke Wang, Shudong Wang	0
2	Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation 2023 ·Molecules ·(unknown), (unknown), Theodosia Teo, (unknown), Laychiluh Mekonnen, Yuchao Yang, Sunita K. C. Basnet, (unknown), Matthew J. Sykes, Mingfeng Yu, Shudong Wang	6
3	2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation 2023 ·Bioorganic & Medicinal Chemistry ·(unknown), Laychiluh Mekonnen, Sunita K. C. Basnet, Theodosia Teo, (unknown), (unknown), (unknown), Solomon Tadesse, Matthew J. Sykes, Mingfeng Yu, Shudong Wang	13
4	An overview of CDK3 in cancer: clinical significance and pharmacological implications 2022 ·Pharmacological Research ·Theodosia Teo, (unknown), Hugo Albrecht, Matthew J. Sykes, Yuchao Yang, Shudong Wang	10
5	Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation 2021 ·European Journal of Medicinal Chemistry ·Mingfeng Yu, Long Yi, Yuchao Yang, Manjun Li, Theodosia Teo, Benjamin Noll, (unknown), Shudong Wang	9
6	Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation 2021 ·European Journal of Medicinal Chemistry ·Mingfeng Yu, Theodosia Teo, Yuchao Yang, Manjun Li, Long Yi, (unknown), Benjamin Noll, (unknown), Sarah Diab, Preethi Eldi, Laychiluh Mekonnen, Abel Tesfaye Anshabo, (unknown), Robert Milne, John D. Hayball, Shudong Wang	14
7	CDK12: a potential therapeutic target in cancer 2020 ·Drug Discovery Today ·Fatemeh Emadi, Theodosia Teo, (unknown), Shudong Wang	25
8	Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia 2017 ·European Journal of Medicinal Chemistry ·Sarah Diab, (unknown), Peng Li, Theodosia Teo, Sunita K. C. Basnet, (unknown), (unknown), Jingfeng Lu, Jinqiang Hou, Mingfeng Yu, (unknown), Hugo Albrecht, Robert Milne, Shudong Wang	23
9	Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy? 2017 ·Journal of Medicinal Chemistry ·(unknown), Malika Kumarasiri, Theodosia Teo, Mingfeng Yu, Shudong Wang	82
10	Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation 2015 ·European Journal of Medicinal Chemistry ·Mingfeng Yu, (unknown), Sunita K. C. Basnet, Malika Kumarasiri, Sarah Diab, Theodosia Teo, Hugo Albrecht, Shudong Wang	31
11	An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis 2015 ·European Journal of Medicinal Chemistry ·Theodosia Teo, Yuchao Yang, Mingfeng Yu, Sunita K. C. Basnet, (unknown), Jinqiang Hou, Raffaella M. Schmid, Malika Kumarasiri, Sarah Diab, Hugo Albrecht, Matthew J. Sykes, Shudong Wang	23
12	Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2 2015 ·Molecular Pharmacology ·Sunita K. C. Basnet, Sarah Diab, Raffaella M. Schmid, Mingfeng Yu, Yuchao Yang, (unknown), Theodosia Teo, Peng Li, Thomas S. Peat, Hugo Albrecht, Shudong Wang	14
13	Pharmacologic Inhibition of MNKs in Acute Myeloid Leukemia 2015 ·Molecular Pharmacology ·Theodosia Teo, Frankie Lam, Mingfeng Yu, Yuchao Yang, Sunita K. C. Basnet, Hugo Albrecht, Matthew J. Sykes, Shudong Wang	27
14	Dynamical Insights of Mnk2 Kinase Activation by Phosphorylation to Facilitate Inhibitor Discovery 2015 ·Future Medicinal Chemistry ·Malika Kumarasiri, Theodosia Teo, Shudong Wang	6
15	MAP Kinase-Interacting Kinases—Emerging Targets against Cancer 2014 ·Chemistry & Biology ·Sarah Diab, Malika Kumarasiri, Mingfeng Yu, Theodosia Teo, Christopher G. Proud, Robert Milne, Shudong Wang	79
16	Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells 2014 ·Cancer Letters ·Theodosia Teo, Mingfeng Yu, Yuchao Yang, (unknown), Frankie Lam, Matthew J. Sykes, Shudong Wang	38
17	Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation 2014 ·ChemMedChem ·Sarah Diab, Theodosia Teo, Malika Kumarasiri, Peng Li, Mingfeng Yu, Frankie Lam, Sunita K. C. Basnet, Matthew J. Sykes, Hugo Albrecht, Robert Milne, Shudong Wang	71
18	Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure–Activity Relationships, and Biological Activities 2014 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Mingfeng Yu, Julian Adams, Frankie Lam, Theodosia Teo, Peng Li, (unknown), Long‐Jin Zhong, Sarah Diab, Osama Chahrour, (unknown), (unknown), Xiangrui Liu, Shi‐Liang Huang, Christopher J. Sumby, Robert Milne, Carol Midgley, Shudong Wang	27
19	Insights into the Importance of DFD-Motif and Insertion I1 in Stabilizing the DFD-Out Conformation of Mnk2 Kinase 2013 ·ACS Medicinal Chemistry Letters ·Jinqiang Hou, Theodosia Teo, Matthew J. Sykes, Shudong Wang	11
20	Identification of a Novel Oligomerization Disrupting Mutation inCRYΑAAssociated with Congenital Cataract in a South Australian Family 2012 ·Human Mutation ·Kate J. Laurie, (unknown), (unknown), Emmanuelle Souzeau, Tim Chataway, Matthew J. Sykes, Theresa Casey, Theodosia Teo, John Pater, Jamie E. Craig, Shiwani Sharma, Kathryn P. Burdon	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact